Government

WHITE PAPERS AND CASE STUDIES

• The Ripple Effect: A Digitalization Playbook

  As the water sector takes on the escalating challenges of accessibility, affordability, and resilience against climate change, digital solutions have demonstrated the potential to transform water systems.

• Trial Rescue: Leadership Approach To Propel Clinical Development

  Learn how Halloran's assistance was able to improve a rare disease biotechnology company’s development and operations, communication workflow, and avoid the delay of a gene therapy trial.

• Leveraging Machine-Learning For SDTM Mapping

  The Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM) represents trial data in a standardized format for review, but could its preparation be automated?

• Providing Enhanced Manufacturing Data To Contracting Companies

  The life sciences sector is projected to reach $220 billion by 2030. Examine the growth of CDMOs and CMOs, emphasizing the need for digitalization to meet client demands and regulatory standards.

• Design Testing Strategies To Develop A Drug-Device Combination Product

  Leveraging the expertise and experience of a trusted partner can reduce risk and accelerate the time to market for drug-device combination products by creating an optimal Validation Master Plan.

• The Annual Clinical Trials Roundup

  Delve into in-depth analyses of key diseases, players, and geographies influencing the pharmaceutical industry through an overview of Phase 1–3 clinical trials initiated in 2022 across all therapeutic areas.

• 15 Reasons To Implement RFID In Medical Devices

  Discover the importance of integrating RFID technology into medical devices for improved tracking, supply chain management, and patient safety — enhancing security, traceability, and compatibility.

• Digital Transformation Of WWTPs

  The importance today of wastewater treatment plants (WWTPs) is clear, as complex systems made up of different processes whose objective is to eliminate all or part of the pollution present in water, becoming a valuable asset for sustainability and the circular economy.

• Regulatory Considerations For Excipients Used In Lipid Nanoparticles

  Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.

• BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle Times

  Learn about a collaboration that has enabled BioIVT to enhance efficiency and responsiveness to its biopharmaceutical clients.

• Orbal® System for Biological Nutrient Removal

  Discover how a fast-growing community's new WWTP meets new tighter limits on ammonia, phosphorus, and nitrogen for future growth.

• How Can The Industry Drive Down The Cost Of Viral Gene Therapies?

  This article discusses how a combination of optimizing your process development, and process intensification can help drive the cost of dose down.